WASHINGTON (DC News Now) — September is Prostate Cancer Awareness Month, and according to the National Cancer Institute (NCI), approximately one in eight men will be diagnosed with prostate cancer ...
Hosted on MSN
First-of-its-kind genomic test predicts benefit from hormone therapy added to radiation for recurrent prostate cancer
A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after ...
PSA testing and digital rectal exams are crucial for early detection of prostate cancer, enabling timely intervention and improved outcomes. Treatment options include active surveillance, ...
Former President Joe Biden has finished a round of radiation therapy to treat the aggressive form of prostate cancer he was ...
For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced patient-reported side effects compared to longer courses of radiation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results